All Stories

Abeona nets $155M with FDA voucher sale just 2 weeks after gene therapy approval

As Abeona gears up for the commercial rollout of Zevaskyn, the company will have a nice chunk of cash at its disposal thanks to a PRV sale agreement.

May 12, 2025 - 14:39
 0
Abeona nets $155M with FDA voucher sale just 2 weeks after gene therapy approval
As Abeona gears up for the commercial rollout of Zevaskyn, the company will have a nice chunk of cash at its disposal thanks to a PRV sale agreement.
Read More

Tags:

Previous Article

Unicorn Democratizes The Buying And Selling Of Spirits With Online Auctions

Next Article

Fierce Biotech Layoff Tracker 2025: NGM sheds 75% of staff; Insitro shrinks team...

Related Posts

After striking out in bankruptcy court, Johnson & Johnson goes after expert witness in talc cases

After striking out in bankruptcy court, Johnson & Johns...

May 5, 2025  0

Xellia to shutter Copenhagen antibiotics plant, dealing a blow to EU reshoring efforts

Xellia to shutter Copenhagen antibiotics plant, dealing...

May 7, 2025  0

FDA, CDC call for pause of chikungunya shot rollout in older adults

FDA, CDC call for pause of chikungunya shot rollout in ...

May 12, 2025  0